U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Tozinameran
5085ZFP6SJ
Possibly Marketed Outside US
First approved in 2021
General
Names
10
Identifiers
7
Subunits
1
Sugars
2
Linkages
1
Related Substances
1
Tozinameran
5085ZFP6SJ
Possibly Marketed Outside US
First approved in 2021
General
Approval Year
2021
470
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
RNA INGREDIENT BNT-162B2
Preferred Name
English
BNT162B2
Preferred Name
English
BNT-162B2
Preferred Name
English
Tozinameran
Official Name
English
Tozinameran [WHO-DD]
Common Name
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
300000019018
PRIMARY
INN
11889
PRIMARY
FDA UNII
5085ZFP6SJ
PRIMARY
NCI_THESAURUS
C173055
PRIMARY
CAS
2417899-77-3
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
1
Sugars
2
Show
5
20
100
All
entries
Sugar
Site Range
Site Count
Sugar
Site Range
Site Count
D-Ribose (RNA)
1_2-1_4283
4282 / 4283
2'-O-Methyl-Ribose
1_1
1 / 4283
Showing 1 to 2 of 2 entries
Previous
1
Next
Linkages
1
Show
5
20
100
All
entries
Linkage
Site Range
Site Count
Linkage
Site Range
Site Count
Phosphate
1_2-1_4283
4282 / 4282
Showing 1 to 1 of 1 entries
Previous
1
Next
Related Substances
1
ACTIVE MOIETY
5085ZFP6SJ
Tozinameran
